NEW YORK, Aug. 16, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neuromama, Ltd. ("Neuromama" or the "Company") (OTC: NERO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
The investigation concerns whether Neuromama and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On August 15, 2016, the U.S. Securities and Exchange Commission halted trading of Neuromama stock, citing concerns about market manipulation and the accuracy of statements coming from the purported media company. The halt came amid questions regarding the information in the marketplace about who is in control of the Company's operations and management, false statements made to current and potential shareholders about a pending application for listing on the NASDAQ, and potentially manipulative transactions.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP